Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
17th Jan 2014 10:42 am RNS Replacement re block listing application
17th Jan 2014 7:00 am RNS Block Listing Application
14th Jan 2014 7:00 am RNS AstraZeneca provides strategy update at JP Morgan
13th Jan 2014 7:00 am RNS US FDA APPROVES FARXIGAT (DAPAGLIFLOZIN)
9th Jan 2014 7:00 am RNS US FDA Approval of Farxiga (dapagliflozin)
2nd Jan 2014 4:00 pm RNS Total Voting Rights
27th Dec 2013 7:13 am RNS AZ and Shionogi extend Crestor agreement
19th Dec 2013 2:00 pm RNS Director/PDMR Shareholding
19th Dec 2013 7:50 am RNS AZ to acquire BMS share of diabetes assets
17th Dec 2013 6:13 pm RNS STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US
13th Dec 2013 7:14 am RNS Top Line Results From Phase III Study of Lesinurad
13th Dec 2013 7:00 am RNS FDA Advisory Committee Recommends Dapagliflozin
12th Dec 2013 7:00 am RNS FDA Advisory Committee Votes on Metreleptin
6th Dec 2013 7:00 am RNS European Commission Approves Fluenz Tetra
2nd Dec 2013 3:00 pm RNS Blocklisting Interim Review
22nd Nov 2013 1:42 pm RNS XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETES
19th Nov 2013 7:00 am RNS NDA for Naloxegol accepted by US FDA
1st Nov 2013 4:00 pm RNS Total Voting Rights
1st Nov 2013 1:45 pm RNS Director/PDMR Shareholding
31st Oct 2013 7:02 am RNS US Court Decision in Pulmicort Respules Litigation
31st Oct 2013 7:01 am RNS Marc Dunoyer Appointed Chief Financial Officer
31st Oct 2013 7:00 am RNS 3rd Quarter Results
30th Oct 2013 9:00 am RNS Notice of Results
30th Oct 2013 7:00 am RNS ASTRAZENECA ADVANCES BENRALIZUMAB TO PHASE III
22nd Oct 2013 7:00 am RNS AstraZeneca starts phase III study for selumetinib
15th Oct 2013 7:00 am RNS Medimmune acquires Spirogen
7th Oct 2013 7:00 am RNS MedImmune completes Amplimmune acquisition
1st Oct 2013 4:00 pm RNS Total Voting Rights
30th Sep 2013 7:01 am RNS MAA FOR OLAPARIB ACCEPTED BY EMA
27th Sep 2013 7:00 am RNS MAA APPLICATION FOR NALOXEGOL ACCEPTED
20th Sep 2013 12:54 pm RNS Fluenz Tetra receives positive CHMP opinion in EU
4th Sep 2013 7:00 am RNS Starts phase III clinical programme for olaparib
2nd Sep 2013 3:00 pm RNS Total Voting Rights
27th Aug 2013 7:00 am RNS MEDIMMUNE ACQUIRES AMPLIMMUNE
1st Aug 2013 4:00 pm RNS Total Voting Rights
1st Aug 2013 3:00 pm RNS Director/PDMR Shareholding
1st Aug 2013 7:00 am RNS Half Yearly Pipeline Update
1st Aug 2013 7:00 am RNS Half Yearly Report
31st Jul 2013 9:00 am RNS Notice of Results
31st Jul 2013 7:00 am RNS Collaborates with FibroGen on anaemia treatment
FTSE 100 Latest
Value8,834.33
Change-3.58